Organoidsciences Ltd. (KOSDAQ:476040)
South Korea flag South Korea · Delayed Price · Currency is KRW
21,400
-1,000 (-4.46%)
At close: Apr 9, 2026

Organoidsciences Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-15,368-11,246-38,687-24,111
Depreciation & Amortization
1,4451,3041,144804.46
Loss (Gain) From Sale of Investments
-479.76-163.05-43.05-
Stock-Based Compensation
830.57969.5979.19542.39
Other Operating Activities
-5.2679.1529,85313,990
Change in Accounts Receivable
-25.39149.39-393.50.78
Change in Inventory
-26.82-26.23-
Change in Accounts Payable
49.510.7414.88-
Change in Income Taxes
--0.74-
Change in Other Net Operating Assets
-435.83-260.43-90.48256.22
Operating Cash Flow
-13,989-9,141-7,248-8,518
Capital Expenditures
-1,923-667.07-947.83-1,787
Sale of Property, Plant & Equipment
--6.16-
Sale (Purchase) of Intangibles
-41.35-120.21-70.5-16.88
Investment in Securities
-6,0385,7615,632-25,434
Other Investing Activities
-180.45-48.27-19.93-1,094
Investing Cash Flow
-8,1824,9254,600-28,332
Short-Term Debt Issued
-3,000-300
Long-Term Debt Issued
-700--
Total Debt Issued
-3,700-300
Short-Term Debt Repaid
--300--
Long-Term Debt Repaid
-473.78-217.49-218-231.04
Total Debt Repaid
-473.78-517.49-218-231.04
Net Debt Issued (Repaid)
-473.783,183-21868.96
Issuance of Common Stock
25,236200250-
Other Financing Activities
644.44280.79148.42218.27
Financing Cash Flow
25,4073,663180.4311,286
Foreign Exchange Rate Adjustments
56.9844.82-74.93-
Net Cash Flow
3,292-507.22-2,543-25,563
Free Cash Flow
-15,912-9,808-8,196-10,304
Free Cash Flow Margin
-661.20%-502.11%-515.13%-2351.33%
Free Cash Flow Per Share
-2606.13-2346.73-2859.93-3595.68
Cash Interest Paid
349.7301.32341.67123.02
Cash Income Tax Paid
-37.03-34.04114.09-
Levered Free Cash Flow
-8,204-68,92415,049-
Unlevered Free Cash Flow
-7,977-66,93018,794-
Change in Working Capital
-411.72-83.47-494.59257
Source: S&P Global Market Intelligence. Standard template. Financial Sources.